Coldstream Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,713
Closed -$27.8K 1358
2025
Q1
$27.8K Buy
+3,713
New +$27.8K ﹤0.01% 1968